Related Experiment Video

Updated: May 9, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

Identifying term breast-fed infants at risk of significant hyperbilirubinemia

Pi-Feng Chang1, Yu-Cheng Lin, Kevin Liu

  • 11] Department of Pediatrics, Far Eastern Memorial Hospital, Pan-Chiao, New Taipei, Taiwan [2] Oriental Institute of Technology, Pan-Chiao, New Taipei, Taiwan.

Pediatric Research
|July 17, 2013
PubMed

Insights

This study identifies key risk factors for neonatal hyperbilirubinemia in breast-fed infants. Combining third-day bilirubin levels and UGT1A1 gene variants effectively predicts jaundice risk.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Genetics

Background:

  • Neonatal hyperbilirubinemia poses a significant health risk to term breast-fed infants.
  • Early identification of at-risk infants is crucial for timely intervention and prevention of complications.

Purpose of the Study:

  • To develop a predictive model for identifying term breast-fed infants at risk of significant neonatal hyperbilirubinemia.
  • To evaluate specific clinical and genetic factors associated with hyperbilirubinemia development.

Main Methods:

  • A prospective study involving 240 exclusively breast-fed term neonates.
  • Investigated factors including birth weight, delivery mode, G6PD deficiency, predischarge bilirubin, and UGT1A1/SLCO1B1 gene variants.
  • Defined significant hyperbilirubinemia based on American Academy of Pediatrics phototherapy guidelines.

Main Results:

  • 10.8% of infants developed significant hyperbilirubinemia.
  • Predischarge total serum bilirubin (day 3) and variant UGT1A1 gene (nucleotide 211) were significant risk factors.
  • The predictive model demonstrated high accuracy (ROC curve AUC = 0.964).

Conclusions:

  • A combination of third-day total serum bilirubin and the variant UGT1A1 gene at nucleotide 211 effectively predicts hyperbilirubinemia in term breast-fed infants.
  • This model can aid in early risk stratification and management of neonatal jaundice.
Abstract

More Related Videos

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...